These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 35190047)
21. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths. Soman R; Sunavala A J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262 [No Abstract] [Full Text] [Related]
22. COVID-19, steroids, and mucormycosis: What an ophthalmologist should know. Tandon A; Pandey L Indian J Ophthalmol; 2021 Jul; 69(7):1970. PubMed ID: 34146077 [No Abstract] [Full Text] [Related]
26. Mucormycosis-A serious threat in the COVID-19 pandemic? Szarpak L; Chirico F; Pruc M; Szarpak L; Dzieciatkowski T; Rafique Z J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34029629 [No Abstract] [Full Text] [Related]
27. Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times. Singh AK; Singh R Indian J Ophthalmol; 2021 Sep; 69(9):2552. PubMed ID: 34427273 [No Abstract] [Full Text] [Related]
28. Mucormycosis in COVID-19 recovered patients. Kumar A J Med Virol; 2022 Apr; 94(4):1272-1273. PubMed ID: 34905224 [No Abstract] [Full Text] [Related]
30. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it? Gupta A; Sharma A; Chakrabarti A Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000 [No Abstract] [Full Text] [Related]
31. Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times. Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD Indian J Ophthalmol; 2021 Sep; 69(9):2553. PubMed ID: 34427274 [No Abstract] [Full Text] [Related]
32. Commentary: COVID-19-associated mucormycosis: The ongoing battle. Nair AG Indian J Ophthalmol; 2021 Dec; 69(12):3683-3684. PubMed ID: 34827022 [No Abstract] [Full Text] [Related]
33. COVID-19, DM and Mucormycosis: Prevention is a Mother of Cure. Bawaskar HS J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436838 [No Abstract] [Full Text] [Related]
35. Optical Coherence Tomography of Retinal Artery Occlusion Associated With Mucormycosis and COVID-19. Kaur R; Khan B; Sharma A JAMA Ophthalmol; 2021 Nov; 139(11):e214064. PubMed ID: 34787678 [No Abstract] [Full Text] [Related]
36. Response to: COVID-19-associated mucormycosis and evolving evidence. Sarda R; Swain S; Ray A; Wig N QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346 [No Abstract] [Full Text] [Related]
37. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19). Karimi-Galougahi M; Arastou S; Haseli S Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565 [No Abstract] [Full Text] [Related]
38. [Pediatric rhino-orbital mucormycosis. First peruvian case in times of the COVID-19 pandemic]. Meregildo-Rodriguez ED; Espino-Saavedra WG Rev Peru Med Exp Salud Publica; 2021; 38(3):472-473. PubMed ID: 34932752 [No Abstract] [Full Text] [Related]
39. Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess? Nair AG Indian J Ophthalmol; 2022 Mar; 70(3):1024-1025. PubMed ID: 35225565 [No Abstract] [Full Text] [Related]
40. Mucormycosis-Related Vision Loss in COVID-19. Dhoot SK Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]